株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

治験管理システムの世界市場の将来予測

Global Clinical Trial Management Market Forecast 2019-2027

発行 Inkwood Research 商品コード 816232
出版日 ページ情報 英文 124 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=112.86円で換算しております。
Back to Top
治験管理システムの世界市場の将来予測 Global Clinical Trial Management Market Forecast 2019-2027
出版日: 2019年04月01日 ページ情報: 英文 124 Pages
概要

当レポートでは、世界の治験管理システム (CTM) 市場の将来展望について分析し、主な市場促進・抑制要因や、全体的な市場動向の見通し (今後9年間分)、展開方式別・エンドユース別・製品種類別・コンポーネント別および地域別の詳細動向、市場の競争環境および求心力、各国政府の関連規制・政策、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 市場の範囲と定義
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 展開方式別の市場

  • Webベース
  • クラウド
  • オンプレミス

第6章 エンドユーザー別の市場

  • 製薬企業、バイオ医薬品企業
  • CRO (医薬品開発業務受託機関)
  • 医療提供者

第7章 製品種類別の市場

  • 企業ベース
  • 現場ベース

第8章 コンポーネント別の市場

  • ソフトウェア
  • ハードウェア
  • サービス

第9章 主な分析指標

  • ポーターのファイブフォース分析
    • 新規参入企業の脅威
    • 代替製品/サービスの脅威
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 企業間競争
  • 市場機会マトリックス
  • ベンダー環境

第10章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、フランス、ドイツ、イタリア、スペイン、ロシアなど)
  • アジア太平洋地域 (インド、中国、日本、韓国、オーストラリアなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第11章 競争環境

  • 企業プロファイル
    • MEDIDATA SOLUTIONS, INC.
    • ARISGLOBAL LLC
    • BIOCLINICA INC.
    • BIO-OPTRONICS INC.
    • FORTE RESEARCH SYSTEMS INC.
    • ORACLE CORPORATION
    • IBM CORPORATION
    • MEDNET SOLUTIONS INC.
    • PAREXEL INTERNATIONAL CORPORATION
    • VEEVA SYSTEMS INC.
図表

LIST OF TABLES

  • TABLE 1 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)
  • TABLE 2 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2019-2027, (IN $ MILLION)
  • TABLE 3 GLOBAL WEB-BASED DEPLOYMENT MODEL MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 4 GLOBAL CLOUD DEPLOYMENT MODEL MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 5 GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 6 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END USER, 2019-2027, (IN $ MILLION)
  • TABLE 7 GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 8 GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 9 GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 10 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2019-2027, (IN $ MILLION)
  • TABLE 11 GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 12 GLOBAL SITE-BASED CTM MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 13 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2019-2027, (IN $ MILLION)
  • TABLE 14 GLOBAL SOFTWARE MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 15 GLOBAL HARDWARE MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 16 GLOBAL SERVICES MARKET, BY REGION, 2019-2027, (IN $ MILLION)
  • TABLE 17 OPPORTUNITY MATRIX
  • TABLE 18 VENDOR LANDSCAPE
  • TABLE 19 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)
  • TABLE 20 NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 21 EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 22 ASIA PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 23 RoW CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET SHARE, BY END-USER 2018 & 2027 (%)
  • FIGURE 2 GLOBAL CLOUD CLINICAL TRIAL MANAGEMENT MARKET, 2019 - 2027 (IN $ MILLION)
  • FIGURE 3 GLOBAL ENTERPRISE-BASED CTM MANAGEMENT, 2019 - 2027 (IN $ MILLION)
  • FIGURE 4 GLOBAL SOFTWARE MARKET FOR CLINICAL TRIAL MANAGEMENT, 2019 - 2027 (IN $ MILLION)
  • FIGURE 5 GLOBAL HEALTHCARE PROVIDERS MARKET FOR CLINICAL TRIAL MANAGEMENT, 2019 - 2027 (IN $ MILLION)
  • FIGURE 6 PORTER'S FIVE FORCE MODEL
  • FIGURE 7GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2018 & 2027, (%)
  • FIGURE 8 UNITED STATES CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 9 CANADA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 10 UK CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 11 FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 12 GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 13 ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 14 SPAIN CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 15 RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 16 ROE CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 17 INDIA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 18 CHINA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 19 JAPAN CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 20 SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 21 AUSTRALIA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 22 RoAPAC CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 23 LATIN AMERICA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 24 MEA CLINICAL TRIAL MANAGEMENT MARKET, 2019-2027 (IN $ MILLION)
目次
Product Code: 24387

KEY FINDINGS

Global clinical trial management (CTM) market is estimated to grow with approx. 11.12% CAGR during the year 2019-2027 and is expected to gain $XX million till the year 2027. Clinical trial management system (CTMS) helps in the maintenance and management of the vast and highly complex data obtained from clinical trials.

Hospitals, medical research institutes, and research centers carry out clinical trials on behalf of pharmaceutical companies. These healthcare providers depend on the clinical trial management products and services for better management of clinical trial data.

MARKET INSIGHTS

The demand for clinical trial management is soaring in the recent years, owing to factors such as an increase in a number of clinical trials conducted, increase in the prevalence of chronic disease, and growing demand for advanced novel drugs and medical devices. Although, the scarcity of skilled healthcare professionals and cost of implementation are hindering the global clinical trial management market.

The global clinical trial management market segments include deployment model, end-user, product type, component, and region.

REGIONAL INSIGHTS

Geographically, the global clinical trial management market has been segmented on the basis of four major regions, which includes North America, Europe, Asia Pacific and the Rest of World.

North America is the major contributor toward the market growth due to the presence of high disposable income, a large number of clinical trials conducted in the region, the presence of major pharmaceutical companies, and high awareness regarding the benefits of using CTM. The North America region had generated a lumping sum of $xx million in 2018 and is projected to reach $xx million by 2027, registering a market share of XX% by 2027.

COMPETITIVE INSIGHTS

Forte Research Systems Inc., Mednet Solutions Inc., Bio-Optronics Inc., Medidata Solutions, Inc., Bioclinica Inc., Oracle Corporation, IBM Corporation, Veeva Systems Inc., Arisglobal LLC, and Parexel International Corporation are the major companies operating in the global market.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CLOUD MODEL OF DEPLOYMENT IS THE FASTEST GROWING MODEL IN CLINICAL TRIAL MANAGEMENT MARKET
    • 3.2.2. ENTERPRISE-BASED CTM IS THE LARGEST PRODUCT TYPE IN THE MARKET
    • 3.2.3. SOFTWARE IS THE LARGEST COMPONENT IN CLINICAL TRIAL MANAGEMENT MARKET
    • 3.2.4. HEALTHCARE PROVIDERS ARE THE FASTEST GROWING END-USERS IN MARKET

4. MARKET DYNAMICS

  • 4.1. MARKET DEFINITION & SCOPE
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN THE SHIFT OF CLINICAL TRIALS TOWARDS OUTSOURCING
    • 4.2.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS
    • 4.2.3. RISE IN THE INCIDENCES OF CHRONIC DISEASES
    • 4.2.4. AWARENESS REGARDING THE BENEFITS OF USING CTM
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
    • 4.3.2. COST OF IMPLEMENTATION
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. BOOST IN EXPENDITURE FOR R&D ACTIVITIES TO IMPLEMENT CTM
  • 4.5. MARKET CHALLENGES
    • 4.5.1. SECURITY CONCERNS

5. MARKET BY DEPLOYMENT MODEL

  • 5.1. WEB-BASED DEPLOYMENT MODEL
  • 5.2. CLOUD DEPLOYMENT MODEL
  • 5.3. ON-PREMISE DEPLOYMENT MODEL

6. MARKET BY END-USER

  • 6.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 6.2. CLINICAL RESEARCH ORGANIZATIONS
  • 6.3. HEALTHCARE PROVIDERS

7. MARKET BY PRODUCT TYPE

  • 7.1. ENTERPRISE-BASED CTM
  • 7.2. SITE-BASED CTM

8. MARKET BY COMPONENT

  • 8.1. SOFTWARE
  • 8.2. HARDWARE
  • 8.3. SERVICES

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCE MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF SUPPLIERS
    • 9.1.4. BARGAINING POWER OF BUYERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. OPPORTUNITY MATRIX
  • 9.3. VENDOR LANDSCAPE

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. UNITED STATES
    • 10.1.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. UK
    • 10.2.2. FRANCE
    • 10.2.3. GERMANY
    • 10.2.4. ITALY
    • 10.2.5. SPAIN
    • 10.2.6. RUSSIA
    • 10.2.7. REST OF EUROPE (ROE)
  • 10.3. ASIA PACIFIC
    • 10.3.1. INDIA
    • 10.3.2. CHINA
    • 10.3.3. JAPAN
    • 10.3.4. SOUTH KOREA
    • 10.3.5. AUSTRALIA
    • 10.3.6. REST OF ASIA PACIFIC (RoAPAC)
  • 10.4. REST OF WORLD (RoW)
    • 10.4.1. LATIN AMERICA
    • 10.4.2. MIDDLE EAST AND AFRICA (MEA)

11. COMPETITIVE LANDSCAPE

  • 11.1. COMPANY PROFILE
    • 11.1.1. MEDIDATA SOLUTIONS, INC.
    • 11.1.2. ARISGLOBAL LLC
    • 11.1.3. BIOCLINICA INC.
    • 11.1.4. BIO-OPTRONICS INC.
    • 11.1.5. FORTE RESEARCH SYSTEMS INC.
    • 11.1.6. ORACLE CORPORATION
    • 11.1.7. IBM CORPORATION
    • 11.1.8. MEDNET SOLUTIONS INC.
    • 11.1.9. PAREXEL INTERNATIONAL CORPORATION
    • 11.1.10. VEEVA SYSTEMS INC.
Back to Top